US5698711A
(en)
|
1991-01-28 |
1997-12-16 |
Rhone-Poulenc Rorer Limited |
Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic- or heteroatom-containing linking group
|
GB9311281D0
(en)
*
|
1993-06-01 |
1993-07-21 |
Rhone Poulenc Rorer Ltd |
Novel composition of matter
|
GB9212673D0
(en)
*
|
1992-06-15 |
1992-07-29 |
Celltech Ltd |
Chemical compounds
|
US5679696A
(en)
*
|
1992-07-28 |
1997-10-21 |
Rhone-Poulenc Rorer Limited |
Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic-or heteroatom-containing linking group
|
GB9222253D0
(en)
*
|
1992-10-23 |
1992-12-09 |
Celltech Ltd |
Chemical compounds
|
WO1994012461A1
(en)
*
|
1992-12-02 |
1994-06-09 |
Pfizer Inc. |
Catechol diethers as selective pdeiv inhibitors
|
US5814651A
(en)
*
|
1992-12-02 |
1998-09-29 |
Pfizer Inc. |
Catechol diethers as selective PDEIV inhibitors
|
GB9226830D0
(en)
*
|
1992-12-23 |
1993-02-17 |
Celltech Ltd |
Chemical compounds
|
TW263495B
(es)
*
|
1992-12-23 |
1995-11-21 |
Celltech Ltd |
|
US5622977A
(en)
*
|
1992-12-23 |
1997-04-22 |
Celltech Therapeutics Limited |
Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same
|
GB9304920D0
(en)
*
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
GB9304919D0
(en)
*
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
ES2229221T3
(es)
*
|
1993-06-18 |
2005-04-16 |
Smithkline Beecham Corporation |
Procedimiento de identificacion de un inhibidor de pde iv.
|
DE69430747T2
(de)
|
1993-07-28 |
2003-03-06 |
Aventis Pharma Ltd |
Verbindungen als pde iv und tnf inhibitoren
|
US5665754A
(en)
*
|
1993-09-20 |
1997-09-09 |
Glaxo Wellcome Inc. |
Substituted pyrrolidines
|
BR9408174A
(pt)
*
|
1993-11-26 |
1997-05-27 |
Pfizer |
Compostos isoxazolina como agentes antiinflamatórios
|
JP2818820B2
(ja)
*
|
1993-11-26 |
1998-10-30 |
ファイザー・インク. |
抗炎症剤としての3−アリール−2−イソオキサゾリン類
|
WO1995017399A1
(en)
*
|
1993-12-22 |
1995-06-29 |
Celltech Therapeutics Limited |
Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitors
|
GB9326173D0
(en)
*
|
1993-12-22 |
1994-02-23 |
Celltech Ltd |
Chemical compounds and process
|
CA2143143A1
(en)
*
|
1994-03-08 |
1995-09-09 |
Toshihiko Tanaka |
3-phenylpyrrolidine derivatives
|
AU684887B2
(en)
*
|
1994-03-09 |
1998-01-08 |
Pfizer Inc. |
Isoxazoline compounds as inhibitors of TNF release
|
CA2184914C
(en)
*
|
1994-03-09 |
2000-09-19 |
Victoria L. Cohan |
Isoxazoline compounds as 5-lipoxygenase inhibitors
|
US5672622A
(en)
*
|
1994-04-21 |
1997-09-30 |
Berlex Laboratories, Inc. |
Treatment of multiple sclerosis
|
DK0758233T3
(da)
*
|
1994-04-21 |
2004-03-22 |
Schering Ag |
PDE IV-inhibitorer til behandling af multipel sklerose
|
EP1380291A1
(en)
*
|
1994-04-21 |
2004-01-14 |
Schering Aktiengesellschaft |
PDE IV inhibitors for treating multiple sclerosis
|
US6060501A
(en)
*
|
1994-06-02 |
2000-05-09 |
Schering Aktiengesellschaft |
Combined treatment of multiple sclerosis
|
US5998428A
(en)
*
|
1995-05-31 |
1999-12-07 |
Smithkline Beecham Corporation |
Compounds and methods for treating PDE IV-related diseases
|
US5786354A
(en)
*
|
1994-06-21 |
1998-07-28 |
Celltech Therapeutics, Limited |
Tri-substituted phenyl derivatives and processes for their preparation
|
US6245774B1
(en)
|
1994-06-21 |
2001-06-12 |
Celltech Therapeutics Limited |
Tri-substituted phenyl or pyridine derivatives
|
GB9412571D0
(en)
*
|
1994-06-22 |
1994-08-10 |
Celltech Ltd |
Chemical compounds
|
GB9412573D0
(en)
|
1994-06-22 |
1994-08-10 |
Celltech Ltd |
Chemical compounds
|
GB9412672D0
(en)
*
|
1994-06-23 |
1994-08-10 |
Celltech Ltd |
Chemical compounds
|
US5591776A
(en)
*
|
1994-06-24 |
1997-01-07 |
Euro-Celtique, S.A. |
Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
|
US5563143A
(en)
*
|
1994-09-21 |
1996-10-08 |
Pfizer Inc. |
Catechol diether compounds as inhibitors of TNF release
|
US5665737B1
(en)
*
|
1994-10-12 |
1999-02-16 |
Euro Celtique Sa |
Substituted benzoxazoles
|
US6066641A
(en)
*
|
1994-12-13 |
2000-05-23 |
Euro-Celtique S.A. |
Aryl thioxanthines
|
EP0804192A1
(de)
*
|
1995-02-10 |
1997-11-05 |
Schering Aktiengesellschaft |
Pharmazeutische präparate zur tnf-inhibition
|
US6268373B1
(en)
|
1995-06-07 |
2001-07-31 |
Euro-Celtique S.A. |
Trisubstituted thioxanthines
|
US5658940A
(en)
*
|
1995-10-06 |
1997-08-19 |
Celgene Corporation |
Succinimide and maleimide cytokine inhibitors
|
DE19540475A1
(de)
*
|
1995-10-20 |
1997-04-24 |
Schering Ag |
Chirale Methylphenyloxazolidinone
|
GB9523675D0
(en)
|
1995-11-20 |
1996-01-24 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9526245D0
(en)
*
|
1995-12-21 |
1996-02-21 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9526246D0
(en)
*
|
1995-12-21 |
1996-02-21 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9608435D0
(en)
*
|
1996-04-24 |
1996-06-26 |
Celltech Therapeutics Ltd |
Chemical compounds
|
CN1080260C
(zh)
*
|
1996-06-25 |
2002-03-06 |
美国辉瑞有限公司 |
取代的吲哚衍生物以及它们作为iv型磷酸二酯酶(pde)和肿瘤坏死因子(tnf)抑制剂的用途
|
GB9619284D0
(en)
*
|
1996-09-16 |
1996-10-30 |
Celltech Therapeutics Ltd |
Chemical compounds
|
US5744473A
(en)
*
|
1996-09-16 |
1998-04-28 |
Euro-Celtique, S.A. |
PDE IV inhibitors: "bis-compounds"
|
GB9622363D0
(en)
*
|
1996-10-28 |
1997-01-08 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9625184D0
(en)
*
|
1996-12-04 |
1997-01-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
US6057329A
(en)
*
|
1996-12-23 |
2000-05-02 |
Celltech Therapeutics Limited |
Fused polycyclic 2-aminopyrimidine derivatives
|
GB9705361D0
(en)
*
|
1997-03-14 |
1997-04-30 |
Celltech Therapeutics Ltd |
Chemical compounds
|
KR19980074060A
(ko)
*
|
1997-03-21 |
1998-11-05 |
김윤배 |
신규한 치환된 3,4-디알콕시페닐 유도체
|
GB9713087D0
(en)
*
|
1997-06-20 |
1997-08-27 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9914258D0
(en)
|
1999-06-18 |
1999-08-18 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9924862D0
(en)
|
1999-10-20 |
1999-12-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
US6376489B1
(en)
*
|
1999-12-23 |
2002-04-23 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
US6680336B2
(en)
|
1999-12-15 |
2004-01-20 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
US6348602B1
(en)
|
1999-12-23 |
2002-02-19 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
US6372777B1
(en)
|
1999-12-23 |
2002-04-16 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
FR2803593B1
(fr)
*
|
2000-01-06 |
2002-02-15 |
Sanofi Synthelabo |
Nouvelles tetrahydropyridines, procede pour leur preparation et compositions pharmaceutiques les contenant
|
WO2001068600A2
(en)
|
2000-03-16 |
2001-09-20 |
Inflazyme Pharmaceuticals Limited |
Benzylated pde4 inhibitors
|
IT1317049B1
(it)
|
2000-06-23 |
2003-05-26 |
Sigma Tau Ind Farmaceuti |
Composti utili per la preparazione di medicamenti ad attivita'inibitrice della fosfodiesterasi iv.
|
WO2002081447A1
(en)
*
|
2001-04-06 |
2002-10-17 |
Daewoong Pharmaceutical Co., Ltd. |
3-cyclopentyloxy-4-methoxyphenyl-isothiazolinone derivatives and the use thereof
|
WO2002081446A1
(en)
*
|
2001-04-06 |
2002-10-17 |
Daewoong Co., Ltd. |
3-cyclopentyloxy-4-methoxyphenyl-isoindolinone derivatives and the use thereof
|
FR2823748B1
(fr)
*
|
2001-04-20 |
2004-02-20 |
Sanofi Synthelabo |
Tetrahydropyridyl-alkyl-benzodiazines, procede pour leur preparation et compositions pharmaceutiques les contenant
|
MEP13408A
(en)
|
2001-05-29 |
2010-06-10 |
Bayer Schering Pharma Ag |
Cdk inhibiting pyrimidines, production thereof and their use as medicaments
|
WO2003032981A1
(en)
*
|
2001-10-16 |
2003-04-24 |
Memory Pharmaceuticals Corporation |
4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes
|
JP2004107323A
(ja)
*
|
2002-07-26 |
2004-04-08 |
Nippon Nohyaku Co Ltd |
新規なハロアルキルスルホンアニリド誘導体及び除草剤並びにその使用方法
|
WO2004011429A1
(ja)
*
|
2002-07-26 |
2004-02-05 |
Nihon Nohyaku Co., Ltd. |
新規なハロアルキルスルホンアニリド誘導体及び除草剤並びにその使用方法
|
CN100439337C
(zh)
|
2002-11-26 |
2008-12-03 |
辉瑞产品公司 |
作为ppar活化剂的苯基取代的哌啶化合物
|
RU2005135330A
(ru)
*
|
2003-04-16 |
2006-06-27 |
Мемори Фармасьютиклз Корпорейшн (Us) |
Ингибиторы фосфодиэстеразы 4
|
AU2004232973A1
(en)
|
2003-04-18 |
2004-11-04 |
Memory Pharmaceuticals Corporation |
Pyrazole derivatives as phosphodiesterase 4 inhibitors
|
GB0401334D0
(en)
|
2004-01-21 |
2004-02-25 |
Novartis Ag |
Organic compounds
|
GB0411056D0
(en)
|
2004-05-18 |
2004-06-23 |
Novartis Ag |
Organic compounds
|
EP1813284A1
(en)
*
|
2004-10-13 |
2007-08-01 |
Kyowa Hakko Kogyo Co., Ltd. |
Pharmaceutical composition
|
WO2006041121A1
(ja)
*
|
2004-10-13 |
2006-04-20 |
Kyowa Hakko Kogyo Co., Ltd. |
慢性皮膚疾患の治療および/または予防剤
|
CN101166733A
(zh)
|
2004-10-15 |
2008-04-23 |
记忆药物公司 |
作为磷酸二酯酶4抑制剂的吡唑衍生物
|
JP2008517066A
(ja)
|
2004-10-20 |
2008-05-22 |
メモリー ファーマシューティカルス コーポレーション |
ホスホジエステラーゼ4阻害剤
|
GT200500281A
(es)
|
2004-10-22 |
2006-04-24 |
Novartis Ag |
Compuestos organicos.
|
GB0424284D0
(en)
|
2004-11-02 |
2004-12-01 |
Novartis Ag |
Organic compounds
|
GB0426164D0
(en)
|
2004-11-29 |
2004-12-29 |
Novartis Ag |
Organic compounds
|
US7517870B2
(en)
|
2004-12-03 |
2009-04-14 |
Fondazione Telethon |
Use of compounds that interfere with the hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/or reversing ocular diseases related with ocular neovascularization
|
GB0507577D0
(en)
|
2005-04-14 |
2005-05-18 |
Novartis Ag |
Organic compounds
|
GB0510390D0
(en)
|
2005-05-20 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
BRPI0617485B8
(pt)
|
2005-10-21 |
2021-05-25 |
Novartis Ag |
anticorpo anti-il-13 humano isolado, composição farmacêutica e uso do referido anticorpo
|
GB0526244D0
(en)
|
2005-12-22 |
2006-02-01 |
Novartis Ag |
Organic compounds
|
GB0601951D0
(en)
|
2006-01-31 |
2006-03-15 |
Novartis Ag |
Organic compounds
|
SI2013211T1
(sl)
|
2006-04-21 |
2012-07-31 |
Novartis Ag |
Purinski derivati za uporabo kot agonisti receptorja adenozina A A
|
MX2009003185A
(es)
|
2006-09-29 |
2009-04-03 |
Novartis Ag |
Pirazolopirimidinas como inhibidores de lipido cinasa pi3k.
|
CA2667962A1
(en)
|
2006-10-30 |
2008-05-08 |
Novartis Ag |
Heterocyclic compounds as antiinflammatory agents
|
WO2008085608A1
(en)
|
2007-01-10 |
2008-07-17 |
Irm Llc |
Compounds and compositions as channel activating protease inhibitors
|
PE20090733A1
(es)
|
2007-05-07 |
2009-07-17 |
Novartis Ag |
Derivados de pirazina como bloqueadores de los canales de sodio epitelial
|
BRPI0820669A2
(pt)
|
2007-12-10 |
2020-08-04 |
Novartis Ag |
compostos orgânicos
|
PT2231642E
(pt)
|
2008-01-11 |
2014-03-12 |
Novartis Ag |
Pirimidinas como inibidores de quinase
|
ES2535736T3
(es)
|
2008-06-10 |
2015-05-14 |
Novartis Ag |
Derivados de pirazina como bloqueadores de los canales de sodio epitelial
|
PL2391366T3
(pl)
|
2009-01-29 |
2013-04-30 |
Novartis Ag |
Podstawione benzimidazole do leczenia gwiaździaków
|
US8389526B2
(en)
|
2009-08-07 |
2013-03-05 |
Novartis Ag |
3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
|
KR20120089643A
(ko)
|
2009-08-12 |
2012-08-13 |
노파르티스 아게 |
헤테로시클릭 히드라존 화합물, 및 암 및 염증을 치료하기 위한 그의 용도
|
WO2011022439A1
(en)
|
2009-08-17 |
2011-02-24 |
Intellikine, Inc. |
Heterocyclic compounds and uses thereof
|
JP5775871B2
(ja)
|
2009-08-20 |
2015-09-09 |
ノバルティス アーゲー |
ヘテロ環式オキシム化合物
|
AU2010310449A1
(en)
|
2009-10-22 |
2012-05-03 |
Vertex Pharmaceuticals Incorporated |
Compositions for treatment of cystic fibrosis and other chronic diseases
|
US8247436B2
(en)
|
2010-03-19 |
2012-08-21 |
Novartis Ag |
Pyridine and pyrazine derivative for the treatment of CF
|
US8637516B2
(en)
|
2010-09-09 |
2014-01-28 |
Irm Llc |
Compounds and compositions as TRK inhibitors
|
WO2012034095A1
(en)
|
2010-09-09 |
2012-03-15 |
Irm Llc |
Compounds and compositions as trk inhibitors
|
US8372845B2
(en)
|
2010-09-17 |
2013-02-12 |
Novartis Ag |
Pyrazine derivatives as enac blockers
|
EP2673277A1
(en)
|
2011-02-10 |
2013-12-18 |
Novartis AG |
[1, 2, 4]triazolo [4, 3 -b]pyridazine compounds as inhibitors of the c-met tyrosine kinase
|
US9127000B2
(en)
|
2011-02-23 |
2015-09-08 |
Intellikine, LLC. |
Heterocyclic compounds and uses thereof
|
US9102671B2
(en)
|
2011-02-25 |
2015-08-11 |
Novartis Ag |
Compounds and compositions as TRK inhibitors
|
US8883819B2
(en)
|
2011-09-01 |
2014-11-11 |
Irm Llc |
Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
|
CA2848809A1
(en)
|
2011-09-15 |
2013-03-21 |
Novartis Ag |
6-substituted 3-(quinolin-6-ylthio)-[1,2,4]triazolo[4,3-a]pyradines as c-met tyrosine kinase
|
WO2013038381A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Pyridine/pyrazine amide derivatives
|
WO2013038386A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Heterocyclic compounds for the treatment of cystic fibrosis
|
WO2013038378A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Pyridine amide derivatives
|
WO2013038373A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Pyridine amide derivatives
|
EP2755652B1
(en)
|
2011-09-16 |
2021-06-02 |
Novartis AG |
N-substituted heterocyclyl carboxamides
|
WO2013078440A2
(en)
|
2011-11-23 |
2013-05-30 |
Intellikine, Llc |
Enhanced treatment regimens using mtor inhibitors
|
US8809340B2
(en)
|
2012-03-19 |
2014-08-19 |
Novartis Ag |
Crystalline form
|
MX371119B
(es)
|
2012-04-03 |
2020-01-17 |
Novartis Ag |
Productos de combinacion con los inhibidores de cinasa de tirosina y su uso.
|
US9073921B2
(en)
|
2013-03-01 |
2015-07-07 |
Novartis Ag |
Salt forms of bicyclic heterocyclic derivatives
|
CA2906542A1
(en)
|
2013-03-15 |
2014-09-25 |
Intellikine, Llc |
Combination of kinase inhibitors and uses thereof
|
TW201605450A
(zh)
|
2013-12-03 |
2016-02-16 |
諾華公司 |
Mdm2抑制劑與BRAF抑制劑之組合及其用途
|
KR20160141856A
(ko)
|
2014-04-24 |
2016-12-09 |
노파르티스 아게 |
포스파티딜이노시톨 3-키나제 억제제로서의 피라진 유도체
|
WO2015162459A1
(en)
|
2014-04-24 |
2015-10-29 |
Novartis Ag |
Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
|
US10112926B2
(en)
|
2014-04-24 |
2018-10-30 |
Novartis Ag |
Amino pyridine derivatives as phosphatidylinositol 3-kinase inhibitors
|
WO2016011658A1
(en)
|
2014-07-25 |
2016-01-28 |
Novartis Ag |
Combination therapy
|
EP3174869B1
(en)
|
2014-07-31 |
2020-08-19 |
Novartis AG |
Combination therapy of a met inhibitor and an egfr inhibitor
|
CN113891744A
(zh)
|
2019-06-10 |
2022-01-04 |
诺华股份有限公司 |
用于治疗cf、copd和支气管扩张的吡啶和吡嗪衍生物
|
MX2022002374A
(es)
|
2019-08-28 |
2022-03-29 |
Novartis Ag |
Derivados de 1,3-fenil heteroarilo sustituidos y su uso en el tratamiento de enfermedades.
|
CN114558002A
(zh)
*
|
2022-03-15 |
2022-05-31 |
四川轻化工大学 |
化合物在制备治疗肿瘤药物中的应用
|